Xenon Pharmaceuticals Inc.
- XENE
- NASDAQ
- Biotechnology
- Neurology Therapeutics
- Clinical-Stage Drug Development
$34.30
Today +2.43%Quote Oct 19, 2026, 04:10 PM UTC
−41.60%over the last month
Max drawdown −41.6%From 1-month high −41.6%3 months −49.3%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Xenon Pharmaceuticals
Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company dedicated to discovering and advancing innovative treatments for individuals living with neurological disorders. The company operates primarily from its headquarters in Burnaby, Canada.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
364
Market value
$3.32B
Quote Oct 19
Floor
$33.41
2.6% below price
Resistance
$34.92
1.8% above price
Price vs analyst targets
22 analysts
Lowest target
$46.00Highest target
$90.00
$46.00Highest target
$90.00
- Price $34.30
- Average target $68.63
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 100% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about XENEPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free